AMRI-59
Product Specifications
UNSPSC Description
AMRI-59 is a potent inhibitor of PrxI used for parasitic infections. AMRI-59 can increase cellular ROS, leading to activation of signaling pathways mediated by mitochondria and apoptosis signal-regulated kinase 1, thereby leading to apoptosis in A549 human lung adenocarcinoma. AMRI-59 exhibits significant antitumor activity without apparent acute toxicity[1].
Target Antigen
Apoptosis; Parasite; Reactive Oxygen Species
Type
Reference compound
Related Pathways
Anti-infection;Apoptosis;Immunology/Inflammation;Metabolic Enzyme/Protease;NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/amri-59.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCC(CC2=CC=C(N3C=CC=C3)C=C2)CC1)NC4=CC=CC(C(C)=O)=C4
Molecular Weight
401.50
References & Citations
[1]Yang YJ, et al. Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I. Antioxid Redox Signal. 2016 Mar 10;24(8):453-69.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111125/AMRI-59-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111125/
Clinical Information
No Development Reported
CAS Number
923515-92-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rat Monoclonal BAFFR/TNFRSF13C Antibody (9B9) [HRP]](https://cdn.genprice.uk/genprice/genprice2.png)
MBS1339233-01 0.02 mg (E-Coli)
Recombinant Clostridium tetani LexA repressor (lexA)
Ask
View Details 